Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2015789718
Up to date per 13.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015789718
Title / Product Name
ZUSAMMENSETZUNGEN ENTHALTEND EIN VIP-ELP FUSIONSPROTEIN ZUR VERWENDUNG IN DER BEHANDLUNG VON MUKOVISZIDOSE
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2015789718
EP Publication Number
3139949
E-Number
1295016
Language
EN
PCT Number
US15029926
Publication Date
15.03.2017 A
29.07.2020 B1
Registration Date
29.07.2020
AT Publication Date
15.08.2020
Application Date
08.05.2015
Registration Number
-
Priorities
08.05.2014
US
201461990425 P
IPC
A61K 38/22 20060101AFI20171023BHEP
Maximum Duration of Protection
08.05.2035
Owner
Phasebio Pharmaceuticals, Inc.
One Great Valley Parkway Suite 30
Malvern, Pennsylvania 19355-1423
US
Representative
No representatives present
Inventor
ARNOLD, Susan
c/o PHASEBIO PHARMACEUTICALS INC. One Great Valley Parkway Suite 30
Malvern, Oregon 19355-1423
US
BALLANCE, David James
c/o PHASEBIO PHARMACEUTICALS INC. One Great Valley Parkway Suite 30
Malvern, Pennsylvania 19355-1423
US
see.ip - Details for ZUSAMMENSETZUNGEN ENTHALTEND EIN VIP-ELP FUSIONSPROTEIN ZUR VERWENDUNG IN DER BEHANDLUNG VON MUKOVISZIDOSE